advertisement

---

Cutaneous and Ocular Toxicology 15

Showing records 1 to 15 | Display all abstracts in Cutaneous and Ocular Toxicology

126918 Predictors of severity in prostaglandin-associated periorbitopathy
Altın Ekin M
Cutaneous and Ocular Toxicology 2025; 44: 126-134

---

126963 Changes in prostaglandin-associated periorbital syndrome: a self-controlled and prospective study
Li W
Cutaneous and Ocular Toxicology 2025; 44: 35-42

---

125679 Adverse effects of topical tacrolimus compounded ophthalmic preparations
Bakather A
Cutaneous and Ocular Toxicology 2025; 44: 186-190

---

126930 Which factor have more adverse effect on ocular surface of patients treated with antiglaucoma drops; drug type, number of drugs or drug intensity?
Altay Y
Cutaneous and Ocular Toxicology 2025; 44: 141-146

---

126918 Predictors of severity in prostaglandin-associated periorbitopathy
Arıkan G
Cutaneous and Ocular Toxicology 2025; 44: 126-134

---

126963 Changes in prostaglandin-associated periorbital syndrome: a self-controlled and prospective study
Chen X
Cutaneous and Ocular Toxicology 2025; 44: 35-42

---

125679 Adverse effects of topical tacrolimus compounded ophthalmic preparations
Amin H
Cutaneous and Ocular Toxicology 2025; 44: 186-190

---

126963 Changes in prostaglandin-associated periorbital syndrome: a self-controlled and prospective study
Chen S
Cutaneous and Ocular Toxicology 2025; 44: 35-42

---

125679 Adverse effects of topical tacrolimus compounded ophthalmic preparations
Nasif W
Cutaneous and Ocular Toxicology 2025; 44: 186-190

---

126918 Predictors of severity in prostaglandin-associated periorbitopathy
Yagmurlu E; Ural Fatihoglu O
Cutaneous and Ocular Toxicology 2025; 44: 126-134

---

126963 Changes in prostaglandin-associated periorbital syndrome: a self-controlled and prospective study
Lv Z
Cutaneous and Ocular Toxicology 2025; 44: 35-42

---

125679 Adverse effects of topical tacrolimus compounded ophthalmic preparations
Shoughy S
Cutaneous and Ocular Toxicology 2025; 44: 186-190

---

126918 Predictors of severity in prostaglandin-associated periorbitopathy
Devebacak A
Cutaneous and Ocular Toxicology 2025; 44: 126-134

---

126963 Changes in prostaglandin-associated periorbital syndrome: a self-controlled and prospective study
Tang J; Li N
Cutaneous and Ocular Toxicology 2025; 44: 35-42

---

126918 Predictors of severity in prostaglandin-associated periorbitopathy
Kartı O; Ayhan Z; Soylev Bajin M
Cutaneous and Ocular Toxicology 2025; 44: 126-134

---